Antiphospholipid Syndrome

Top Story

Cancer, infection risk higher among patients treated with IL inhibitors

Cancer, infection risk higher among patients treated with IL inhibitors
October 29, 2019

Read the Perspective from Teri Puhalsky, RN, CRNI

In the JournalsPerspective

Rivaroxaban does not show noninferiority to vitamin K antagonists in antiphospholipid syndrome

October 14, 2019
Rivaroxaban failed to demonstrate noninferiority to dose-adjusted vitamin K antagonists in patients with thrombotic antiphospholipid syndrome, and the agent even showed…

When Autoimmune Disease Strikes Thrice: Managing Multiple Autoimmune Syndrome

September 20, 2019
By the time Lilly Stairs was diagnosed with psoriatic arthritis at the age of 19 — following an arduous series of tests and doctor visits — she had already…
In the Journals

EULAR: Identifying thrombotic, obstetric risk factors key to managing antiphospholipid syndrome

July 8, 2019
Identifying high-risk factors for thrombotic and obstetric events is crucial in managing antiphospholipid syndrome, and all women with antiphospholipid syndrome should…
More Headlines »

Ace the Case: A 5-Year-Old Girl Presents to the Office With Difficulty Walking

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 5-year-old girl with difficulty…
More »
Meeting News

Heterogeneity still major challenge in connective tissue diseases

May 6, 2019
More »

Early Diagnosis & Optimal Care of Ankylosing Spondylitis

This activity is supported by an independent educational grant from AbbVie.

Ankylosing spondylitis (AS), the most common spondyloarthropathy, is a chronic, progressive, debilitating inflammatory…
More »